版本:
中国

BRIEF-Biosyent extends in-license agreement for cathejell

April 20 Biosyent Inc:

* Biosyent extends in-license agreement for cathejell(r)

* Biosyent Inc - extended its license, distribution and supply agreement with its European partner, Pharmazeutische Fabrik Montavit GES.M.B.H.

* Extensio gives Biosyent Pharma exclusive Canadian rights to cathejell jelly 2 pct product until march 31, 2024 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐